Coremend is a multi-compound research formulation featuring TB-500 (25mg), BPC-157 (10mg), and KPV (10mg). Investigated in preclinical models of inflammatory resolution, angiogenesis, and structural tissue repair. Supplied as a stable lyophilized vial. Third-party HPLC-verified 99% purity. For research use only. Not for human consumption.